The Gateway for Cancer ResearchSM Receives Generous Donation to Continue Funding Innovative Cancer Research Studies

Share Article

A $70,000 donation was made by Cancer Sucks in support of Gateway’s mission to fund bold, new phase I and phase II cancer clinical trials that have potential to saves lives today.

The Gateway for Cancer Research
These dollars will directly support Gateway-funded research studies that aim to improve the lives of loved ones and friends battling cancer today.

The Gateway for Cancer Research, a nonprofit organization that funds innovative, bold and patient-centered cancer clinical trials across the world, has received a generous donation from Cancer Sucks in the amount of $70,000. Cancer Sucks is a nonprofit organization that raises funds in the most creative and fun way to support organizations, such as Gateway, that facilitate cancer research studies.

“We are grateful and humbled to receive such generous funding from Cancer Sucks,” said Karen Kay, director of development at Gateway. “These dollars will directly support Gateway-funded research studies that aim to improve the lives of loved ones and friends battling cancer today.”

The $70,000 contribution comes by way of proceeds raised at the eighth annual Cancer Sucks concert in Tulsa last November, as well as the 2012 Shiprocked Cruise in which Cancer Sucks was the benefiting charity of choice for the event’s lucrative auction of music memorabilia.

“At Cancer Sucks, we provide a forum for those who have lost loved ones to cancer while aggressively raising money to find a cure,” said Cancer Sucks Founder Rick Horton, adding that Cancer Sucks has had tremendous success with non-traditional fundraising events. “We are proud to be a charity with attitude, and our organization is raising money for research through annual car and motorcycle events, along with rock ‘n roll concerts and cruises.”

For more than ten years, Cancer Sucks has been a vocal supporter of Gateway’s mission to fund innovative, conventional and alternative cancer treatment therapies. This recent gift is the largest single donation made by the organization to Gateway.

“There’s great synergy between these two organizations, and our relationship with Cancer Sucks continues to grow,” added Kay. “We are both committed to spreading the urgent message that cancer treatment solutions are needed now, because too many patients are left waiting for answers.”

For the founders of both organizations, cancer is very personal. Cancer Sucks’ Rick Horton and Gateway’s Richard J Stephenson were each moved to establish their respective charities following the passing of their mothers to cancer. Prior to Gateway, Mr. Stephenson established what is known today as Cancer Treatment Centers of America® (CTCA) where patients receive integrative and compassionate cancer care at five hospitals across the country, including one in Tulsa, Okla.

“It is our mission to bring powerful and innovative treatment options to cancer patients. I applaud both Cancer Sucks and Gateway for their tireless efforts to advance the fight against cancer. These are two organizations that are truly making a difference,” said Steve Mackin, president and CEO, Cancer Treatment Centers of America in Tulsa, Okla.

Gateway is a unique cancer research charity in that ninety-nine cents of every dollar received directly funds a phase I or phase II cancer clinical trial – a result of generous underwriting by CTCA. With that, any individual or organization making a financial contribution to Gateway has confidence knowing their dollar is making a real impact in the search for better treatments and cures.

Kay explains that The Gateway for Cancer Research is a passionate and driven organization with a singular vision to see a world in which a cancer diagnosis is no longer feared. To that end, The Gateway supports medical researchers who conduct phase I and phase II cancer clinical trials that aim to help cancer patients feel better, live longer or be cured.

In the past year, Gateway funded thirteen new patient-centered research studies, including one unique combination drug treatment for patients with colorectal cancer, called Two-Step ADAPT therapy. Led by Dr. Edward Lin of the University of Washington, the treatment regimen involves the novel use of an FDA-approved arthritis medication in combination with chemotherapy and radiation therapies to more effectively target, prime and destroy cancer stem cells. This is the first study to specifically target cancer stem cells in colon cancer and has the potential to significantly improve patients’ chance for survival.

“We empower and encourage researchers like Dr. Lin to think outside the box and to introduce bold, new cancer treatment solutions that have the potential to save lives today. With approximately 1,500 people dying from cancer each day, we simply can’t afford to wait any longer for a breakthrough,” Kay added. “The approach and methodology of cancer research needs to be expanded and expedited, and that’s where Gateway comes in. We support forward-thinking researchers and give voice to patients who demand a cure today.”

Visit to learn more, to view patient success stories and to support Gateway’s mission to fund cancer research that can help patients feel better, live longer or be cured today.

About The Gateway for Cancer Research
The Gateway for Cancer Research is a nonprofit 501 (c)(3) organization committed to funding innovative cancer research and bold new ideas for lifesaving treatments that can make a difference today. Thanks to generous underwriting, 99 cents of every dollar received funds phase I and phase II cancer clinical trials all over the world to find better treatments and cures for today’s cancer patients. Since our founding in 1991, Gateway has supported more than 100 clinical trials and funded over $20 million in leading-edge research, including blending the best of conventional and complementary/alternative therapies. It’s time to stop cancer. Get involved today by visiting, like us on Facebook at and join the conversation on Twitter @DemandCures.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Adam Zuckerman
The Gateway For Cancer Research
(847) 342-6704
Email >
Visit website